+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nuclear Medicine Market - Global Forecast 2026-2032- Product Image
Nuclear Medicine Market - Global Forecast 2026-2032- Product Image
New

Nuclear Medicine Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 183 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5206422
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The nuclear medicine market is evolving, driven by rapid innovation and the demand for greater precision in both diagnostic imaging and targeted therapies. Senior leaders face increasing complexity as technology advances and regulatory dynamics reshape the landscape, making informed decision-making vital for sustainable advantage.

Market Snapshot: Nuclear Medicine Market Growth Trajectory

The Nuclear Medicine Market is experiencing strong momentum, expanding from USD 16.05 billion in 2025 to USD 17.72 billion in 2026 and forecasted to reach USD 33.87 billion by 2032, supported by an 11.25% CAGR. Key drivers include advances in radiopharmaceutical technologies and evolving healthcare priorities that encourage wider integration of nuclear-based diagnostics and therapies. These industry shifts underscore the need for senior executives to prioritize innovation alignment and operational readiness as market opportunities accelerate.

Scope & Segmentation of the Global Nuclear Medicine Market

This comprehensive report analyzes the full spectrum of the nuclear medicine market, with close attention to product advancements, reimbursement landscapes, and nuanced regional adoption patterns.

  • Product Types: Includes diagnostic radiopharmaceuticals such as PET and SPECT isotopes, as well as therapeutic nuclear medicine products like brachytherapy isotopes and therapies using alpha or beta emitters, offering expanded clinical options for practitioners.
  • Administration Modes: Highlights intravenous injection as the established standard, while emerging oral formulations introduce new workflow efficiencies and improve the patient care experience.
  • Procedure Categories: Encompasses both digital and analog PET, SPECT imaging techniques, alongside targeted radiopharmaceutical therapies that require specialized infrastructure and advanced staff competencies.
  • Clinical Applications: Addresses a broad clinical spectrum, including cardiology, neurology, oncology, endocrinology, pulmonology, orthopedics, and gastroenterology, demonstrating the versatility of nuclear medicine interventions.
  • End User Segments: Features academic and research institutes, diagnostic centers, and hospital environments—distinguished by government-run and private sector operations—reflecting diverse procurement and practice settings.
  • Regional Focus: Insights span the Americas, Europe/Middle East/Africa, and Asia-Pacific, capturing distinctive regulatory, reimbursement, and logistical frameworks that influence market penetration and competitiveness.
  • Technology Trends: Examines next-generation PET scanners, integration of AI-driven image analysis, decentralized isotope production models, digital workflow enhancements, and innovation in micro-cyclotron systems to support efficient supply chains.

Nuclear Medicine Market: Key Takeaways for Business Leaders

  • Personalized medicine is intensifying sector investment, prompting growth in novel radiopharmaceuticals and enabling tailored clinical solutions.
  • Streamlined regulatory pathways are facilitating quicker adoption of innovative nuclear medicine agents, promoting improved patient access and fast-tracked commercialization.
  • Decentralized and localized supply chain strategies are emerging as pivotal, especially in response to challenges related to geopolitics and logistics that may disrupt core isotope delivery networks.
  • Strategic collaborations among manufacturers, radiopharmacies, and technology organizations are expanding the breadth of integrated service and product offerings for healthcare providers.
  • Adapting research and development to reimbursement transitions, investing in advanced facility infrastructure, and optimizing go-to-market models position organizations to differentiate and lead effectively in this field.

Tariff Impact: Trade Policy Shaping Supply Chains and Operations

Recent U.S. tariff measures introduced in 2025 have led to higher costs and more complex logistics across the nuclear medicine supply chain. With import duties imposing pressure on sourcing components, global manufacturers are re-evaluating both sourcing and production models. While domestic suppliers may gain in certain market segments, they must also address increased demand and maintain compliance. As a result, distribution networks are adopting more robust inventory controls, piloting regional distribution hubs, and leveraging advanced forecasting tools to ensure uninterrupted clinical supply. International partnerships are being renegotiated to bolster supply chain resilience and maintain access to essential radiopharmaceutical materials.

Methodology & Data Sources

The market analysis employs an integrated methodology that combines exhaustive secondary research with selected primary interviews conducted across clinical, scientific, and commercial channels. Segment validations are supported by both bottom-up and top-down market modeling techniques, with scenario analysis and sensitivity checks used to assess stakeholder risk exposure.

Why This Report Matters: Strategic Value for Executives

  • Offers strategic insights for optimizing R&D spend, enhancing supply chain frameworks, and establishing successful partnership models across the nuclear medicine ecosystem.
  • Supplies reliable, segment-focused intelligence that informs regional and global commercial decisions.
  • Equips leaders to proactively address evolving technology, reimbursement policies, and the influence of shifting trade legislation on nuclear medicine operations.

Conclusion

The nuclear medicine market is characterized by rapid innovation, varied clinical applications, and the need for flexible operational strategies. Executives who leverage actionable intelligence and invest in resilient networks are positioned to secure sustainable growth and value as the market continues to advance.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Nuclear Medicine Market, by Product Type
8.1. Diagnostic Radiopharmaceuticals
8.1.1. Positron Emission Tomography (PET) Isotopes
8.1.2. Single Photon Emission Computed Tomography (SPECT) Isotopes
8.2. Therapeutic Nuclear Medicine
8.2.1. Brachytherapy Isotopes
8.2.1.1. Cesium-131
8.2.1.2. Iodine-125
8.2.1.3. Iridium-192
8.2.1.4. Palladium-103
8.2.2. Radiopharmaceutical Therapy
8.2.2.1. Alpha Emitters
8.2.2.2. Beta Emitters
9. Nuclear Medicine Market, by Mode Of Administration
9.1. Intravenous Injection
9.2. Oral Ingestion
10. Nuclear Medicine Market, by Usage
10.1. Diagnostic Procedure
10.1.1. PET Scanners
10.1.1.1. Analog PET
10.1.1.2. Digital PET
10.1.2. SPECT Scanners
10.2. Therapeutic Procedure
11. Nuclear Medicine Market, by Application
11.1. Cardiology
11.2. Endocrinology
11.3. Gastroenterology
11.4. Neurology
11.5. Oncology
11.6. Orthopedics
11.7. Pulmonology
12. Nuclear Medicine Market, by End Users
12.1. Academic & Research Institutes
12.2. Diagnostic Centers
12.3. Hospitals
12.3.1. Government Hospitals
12.3.2. Private Hospitals
13. Nuclear Medicine Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Nuclear Medicine Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Nuclear Medicine Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Nuclear Medicine Market
17. China Nuclear Medicine Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. 3B Pharmaceuticals GmbH
18.6. Actinium Pharmaceuticals, Inc.
18.7. B J Madan & Co.
18.8. Bayer AG
18.9. Bracco S.p.A.
18.10. BWX Technologies, Inc.
18.11. Clarity Pharmaceuticals
18.12. Curium
18.13. Eli Lilly and Company
18.14. GE HealthCare
18.15. IBA
18.16. Institute of Isotopes Co., Ltd
18.17. Isotopia Molecular Imaging Ltd.
18.18. Jubilant Pharma Limited
18.19. Lantheus Holdings, Inc.
18.20. Medi-Radiopharma Co., Ltd.
18.21. Nordion
18.22. Northstar Medical Technologies LLC
18.23. Novartis AG
18.24. Nusano, Inc.
18.25. PeptiDream Inc.
18.26. Radiopharm Theranostics Limited
18.27. SHINE Technologies, LLC
18.28. Siemens Healthineers AG
18.29. Sinotau Pharmaceuticals Group
18.30. South African Nuclear Energy Corporation
18.31. State Atomic Energy Corporation Rosatom
18.32. Thor Medical AS by Nordic Nanovector ASA
List of Figures
FIGURE 1. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL NUCLEAR MEDICINE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL NUCLEAR MEDICINE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA NUCLEAR MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET) ISOTOPES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET) ISOTOPES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET) ISOTOPES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) ISOTOPES, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) ISOTOPES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) ISOTOPES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY INTRAVENOUS INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY INTRAVENOUS INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY INTRAVENOUS INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ORAL INGESTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ORAL INGESTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ORAL INGESTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ANALOG PET, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ANALOG PET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ANALOG PET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIGITAL PET, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIGITAL PET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIGITAL PET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT SCANNERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PROCEDURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PROCEDURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PROCEDURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PULMONOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PULMONOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PULMONOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GOVERNMENT HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GOVERNMENT HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 163. EUROPE NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. EUROPE NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 165. EUROPE NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 166. EUROPE NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
TABLE 167. EUROPE NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2032 (USD MILLION)
TABLE 168. EUROPE NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 169. EUROPE NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 170. EUROPE NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
TABLE 171. EUROPE NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2032 (USD MILLION)
TABLE 172. EUROPE NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2032 (USD MILLION)
TABLE 173. EUROPE NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 174. EUROPE NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 175. EUROPE NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 189. AFRICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. AFRICA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. AFRICA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 192. AFRICA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
TABLE 193. AFRICA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2032 (USD MILLION)
TABLE 194. AFRICA NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 195. AFRICA NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 196. AFRICA NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
TABLE 197. AFRICA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2032 (USD MILLION)
TABLE 198. AFRICA NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2032 (USD MILLION)
TABLE 199. AFRICA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 200. AFRICA NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 201. AFRICA NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 203. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 216. ASEAN NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. ASEAN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 218. ASEAN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 219. ASEAN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
TABLE 220. ASEAN NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2032 (USD MILLION)
TABLE 221. ASEAN NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 222. ASEAN NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 223. ASEAN NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
TABLE 224. ASEAN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2032 (USD MILLION)
TABLE 225. ASEAN NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2032 (USD MILLION)
TABLE 226. ASEAN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 227. ASEAN NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 228. ASEAN NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 229. GCC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 230. GCC NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 231. GCC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 232. GCC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
TABLE 233. GCC NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2032 (USD MILLION)
TABLE 234. GCC NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 235. GCC NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 236. GCC NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
TABLE 237. GCC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2032 (USD MILLION)
TABLE 238. GCC NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2032 (USD MILLION)
TABLE 239. GCC NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 240. GCC NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 241. GCC NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 255. BRICS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. BRICS NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 257. BRICS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 258. BRICS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
TABLE 259. BRICS NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2032 (USD MILLION)
TABLE 260. BRICS NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 261. BRICS NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 262. BRICS NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
TABLE 263. BRICS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2032 (USD MILLION)
TABLE 264. BRICS NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2032 (USD MILLION)
TABLE 265. BRICS NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 266. BRICS NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 267. BRICS NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 268. G7 NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 269. G7 NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 270. G7 NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 271. G7 NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
TABLE 272. G7 NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2032 (USD MILLION)
TABLE 273. G7 NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 274. G7 NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 275. G7 NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
TABLE 276. G7 NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2032 (USD MILLION)
TABLE 277. G7 NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2032 (USD MILLION)
TABLE 278. G7 NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 279. G7 NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 280. G7 NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 281. NATO NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 282. NATO NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 283. NATO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 284. NATO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
TABLE 285. NATO NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2032 (USD MILLION)
TABLE 286. NATO NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 287. NATO NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 288. NATO NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
TABLE 289. NATO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2032 (USD MILLION)
TABLE 290. NATO NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2032 (USD MILLION)
TABLE 291. NATO NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 292. NATO NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 293. NATO NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 294. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 295. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 296. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 297. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 298. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
TABLE 299. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2032 (USD MILLION)
TABLE 300. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 301. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 302. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
TABLE 303. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2032 (USD MILLION)
TABLE 304. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2032 (USD MILLION)
TABLE 305. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 306. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 307. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 308. CHINA NUCLEAR MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 309. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 310. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 311. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
TABLE 312. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2032 (USD MILLION)
TABLE 313. CHINA NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 314. CHINA NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 315. CHINA NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2032 (USD MILLION)
TABLE 316. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2032 (USD MILLION)
TABLE 317. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2032 (USD MILLION)
TABLE 318. CHINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 319. CHINA NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 320. CHINA NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Nuclear Medicine market report include:
  • 3B Pharmaceuticals GmbH
  • Actinium Pharmaceuticals, Inc.
  • B J Madan & Co.
  • Bayer AG
  • Bracco S.p.A.
  • BWX Technologies, Inc.
  • Clarity Pharmaceuticals
  • Curium
  • Eli Lilly and Company
  • GE HealthCare
  • IBA
  • Institute of Isotopes Co., Ltd
  • Isotopia Molecular Imaging Ltd.
  • Jubilant Pharma Limited
  • Lantheus Holdings, Inc.
  • Medi-Radiopharma Co., Ltd.
  • Nordion
  • Northstar Medical Technologies LLC
  • Novartis AG
  • Nusano, Inc.
  • PeptiDream Inc.
  • Radiopharm Theranostics Limited
  • SHINE Technologies, LLC
  • Siemens Healthineers AG
  • Sinotau Pharmaceuticals Group
  • South African Nuclear Energy Corporation
  • State Atomic Energy Corporation Rosatom
  • Thor Medical AS by Nordic Nanovector ASA

Table Information

Report AttributeDetails
No. of Pages183
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 17.72 Billion
Forecasted Market Value ( USD ) by 2032 $ 33.87 Billion
Compound Annual Growth Rate11.2%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Nuclear Medicine Market Report and Forecast 2025-2034 - Product Image

Nuclear Medicine Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Radiopharmaceuticals in Nuclear Medicine Market - Global Forecast 2026-2032 - Product Image

Radiopharmaceuticals in Nuclear Medicine Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Nuclear Medicine Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Nuclear Medicine Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 162 Pages
  • Global
From
Nuclear Medicine & Radiopharmaceuticals Market - Global Forecast 2026-2032 - Product Image

Nuclear Medicine & Radiopharmaceuticals Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Nuclear Medicine Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Nuclear Medicine Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From

About the Nuclear Medicine Market

Nuclear Medicine is a field of medicine that uses radioactive materials to diagnose and treat diseases, particularly cancer. Nuclear Medicine is used to detect and monitor the progression of cancer, as well as to provide targeted treatments. It is used to detect cancer cells in the body, to measure the effectiveness of cancer treatments, and to provide targeted radiation therapy. Nuclear Medicine can also be used to detect and monitor the spread of cancer to other parts of the body. Nuclear Medicine is used in combination with other treatments, such as chemotherapy and surgery, to provide a comprehensive approach to cancer care. It is also used to provide palliative care, to reduce pain and improve quality of life for cancer patients. Nuclear Medicine is a rapidly growing field, with new technologies and treatments being developed to improve the diagnosis and treatment of cancer. Companies in the Nuclear Medicine market include GE Healthcare, Siemens Healthineers, Philips Healthcare, and Toshiba Medical Systems. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.